PANCREATIC POLYPEPTIDE, HUMAN

PANCREATIC POLYPEPTIDE, HUMAN Basic information
Discovery Structure Gene and mRNA Synthesis and release Agonists and antagonists Biological functions Clinical implications
Product Name:PANCREATIC POLYPEPTIDE, HUMAN
Synonyms:M.W. 4181.71 C185H287N53O54S2;H-ALA-PRO-LEU-GLU-PRO-VAL-TYR-PRO-GLY-ASP-ASN-ALA-THR-PRO-GLU-GLN-MET-ALA-GLN-TYR-ALA-ALA-ASP-LEU-ARG-ARG-TYR-ILE-ASN-MET-LEU-THR-ARG-PRO-ARG-TYR-NH2;APLEPVYPGDNATPEQMAQYAADLRRYINMLTRPRY-NH2;ALA-PRO-LEU-GLU-PRO-VAL-TYR-PRO-GLY-ASP-ASN-ALA-THR-PRO-GLU-GLN-MET-ALA-GLN-MET-ALA-GLN-TYR-ALA-ALA-ASP-LEU-ARG-ARG-TYR-ILE-ASN-MET-LEU-THR-ARG-PRO-ARG-TYR-NH2;ALA-PRO-LEU-GLU-PRO-VAL-TYR-PRO-GLY-ASP-ASN-ALA-THR-PRO-GLU-GLN-MET-ALA-GLN-TYR-ALA-ALA-ASP-LEU-ARG-ARG-TYR-ILE-ASN-MET-LEU-THR-ARG-PRO-ARG-TYR-NH2;ALA-PRO-LEU-GLU-PRO-VAL-TYR-PRO-GLY-ASP-ASN-ALA-THR-PRO-GLU-GLN-MET-ALA-GLN-TYR-ALA-ALA-ASP-LEU-ARG-ARG-TYR-ILE-ASN-MET-LEU-THR-ARG-PRO-ARG-TYR-NH2 HUMAN;PP, HUMAN;PANCREATIC POLYPEPTIDE
CAS:75976-10-2
MF:C185H287N53O54S2
MW:4181.71098
EINECS:
Product Categories:Peptide;Neuropeptide Y (NPY ) receptor;Elisa Kit-Mouse Elisa Kit
Mol File:75976-10-2.mol
PANCREATIC POLYPEPTIDE, HUMAN Structure
PANCREATIC POLYPEPTIDE, HUMAN Chemical Properties
storage temp. -15°C
solubility Water: 1 mg/ml
form Powder
Water Solubility Soluble to 0.70 mg/ml in water
Safety Information
MSDS Information
PANCREATIC POLYPEPTIDE, HUMAN Usage And Synthesis
DiscoveryThe pancreatic polypeptide (PP) is a peptide hormone secreted from the pancreas to inhibit pancreatic exocrine secretion, gall bladder contraction, gastric emptying, and gut motility, and to modulate anxiolytic and depressive behaviors. PP was isolated in 1975 as a byproduct of insulin purification from the pancreas.
StructureMature PP is a linear peptide consisting of 36 aa residues in mammals, including humans. PP is a member of the neuropeptide Y (NPY) family, and about 50% homology with NPY and 70% homology with peptide YY (PYY) in pigs. The amino acid sequences of PP are conserved in mammals and other nonmammalian specie. Human PP: Mr. 4182. Soluble in water, acid solutions, and methanol. 
Gene and mRNAThe human PP gene is localized with the NPY gene on chromosome 17p21.31 and consists of four exons. In humans, preproPP has 95 aa residues, comprising a 29-aa signal peptide, a 36-aa mature PP, and a 30-aa C-terminal peptide. PP gene expression is restricted to the pancreas in the fourth cell type, named F cells. The PP-producing F cells often take up a peripheral position in the islets, and are distinct from the three other major islet cell populations, the insulin-producing β cells, the glucagon-producing α cells, and the somatostatin-producing S cells.
Synthesis and releaseA potential AP-1 binding site and several potential AP-2 binding sequences, which are activated by cAMP and phorbol ester, are located upstream of the transcriptional initiation site of the human PP gene. PP is secreted from the F cells of the pancreatic islets. The secretion of PP is increased by protein meal ingestion, fasting, and exercise.
Agonists and antagonistsAgonists and antagonists for the Y4 receptor are discussed in Subchapter 34B.
Biological functionsPP secreted from the pancreas stimulates gastric juice secretion. The peripheral administration of PP decreases food intake in rodents while central administration of PP increases food intake. PP inhibits pancreatic exocrine secretion, gall bladder contraction, gastric emptying, and gutmotility.The peripheral administration of PP causes Y4 receptor-dependent c-Fos expression in the brainstem, hypothalamus, and amygdala. The chronic peripheral administration of PP reduces anxiety.
Clinical implicationsPlasma PP levels are reduced following increased food intake, and elevated in anorexia nervosa. PP administration reduces food intake in lean humans as well as in obese patients with Prader-Willi syndrome. No PP-related peptides and compounds have been used clinically as therapeutic agents.
DescriptionPancreatic polypeptide is an agonist of neuropeptide Y (NPY) receptors that reduces forskolin-induced cAMP accumulation in L-M(TK-) cells recombinantly expressing human and rat Y4 receptors (EC50s = 87.1 and 36.3 pM, respectively). It binds to Y1 and Y5 receptors with Ki values of 19 and 3.9 nM, respectively, for human and 50 and 2.4 nM, respectively, for rhesus monkey receptors. Pancreatic polypeptide also binds to rabbit Y1, Y2, Y4, and Y5 receptors (Kis = 0.39, 0.087, 0.79, and 0.24 nM, respectively). It induces contractile responses in isolated rat colon with EC50 values of 1.6 and 0.7 nM for ascending and descending colon segments, respectively. In vivo, pancreatic polypeptide (0.7-7 nmol, i.c.v.) increases food intake in rats.
Clinical UsePP secretion from the pancreas in response to vagal nerve stimulation has been used as a diagnostic test of vagal nerve function.
storageStore at -20°C
PANCREATIC POLYPEPTIDE, HUMAN Preparation Products And Raw materials
PANCREATIC POLYPEPTIDE, RAT PANCREATIC POLYPEPTIDE (BOVINE) PANCREATIC POLYPEPTIDE (AVIAN) PANCREATIC POLYPEPTIDE (RANA TEMPORARIA) H-LEU-THR-ARG-PRO-ARG-TYR-OH PANCREATIC POLYPEPTIDE (1-17)-(ALA31,AIB32)-NEUROPEPTIDE Y (18-36) (HUMAN) PANCREATIC POLYPEPTIDE (31-36) (HUMAN) ([125I]-TYR)-PANCREATIC POLYPEPTIDE (HUMAN) (GLY1,SER3,22,GLN4,34,THR6,ALA19,TYR21,ALA23,31,AIB32)-PANCREATIC POLYPEPTIDE (HUMAN) TRIFLUOROACETATE SALT NEUROPEPTIDE Y (19-23)-(GLY1,SER3,GLN4,THR6,ALA31,AIB32,GLN34)-PANCREATIC POLYPEPTIDE (HUMAN) PANCREATIC POLYPEPTIDE, HUMAN,PANCREATIC POLYPEPTIDE, HUMAN SYNTHETIC >99% ANTI-PANCREATIC POLYPEPTIDE, HUMAN BIOTINYL-PANCREATIC POLYPEPTIDE (HUMAN) BIOTIN-PANCREATIC POLYPEPTIDE, HUMAN PANCREATIC POLYPEPTIDE, HUMAN FRAGMENT 31-36 PANCREATIC POLYPEPTIDE, (HUMAN) [125I]-

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.